• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News  
Title Created Date
The Synergism of Somatostatin, Melatonin, Vitamins Prolactin and Estrogen Inhibitors Increased Survival, Objective Response and Performance Status In 297 Cases of Breast Cancer 29 May 2018
Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast 04 January 2018
Congenital fibrosarcoma - A 14 year Follow Up! 09 March 2016
Recurrent Glioblastoma Multiforme (grade IV – WHO 2007): a case of complete objective response achieved by means of the concomitant administration of Somatostatin and Octreotide – Retinoids – Vit E – Vit D3 – Vit C – Melatonin – D2 R agonists (Di Bella Me 21 June 2015
Breast cancer: evaluation of the safety and efficacy of the first-line treatment in 20 cases 28 January 2014
Prostate cancer: study on 16 patients 21 January 2014
Low-grade Non-Hodgkin Lymphoma at advanced stage: case report 17 November 2013
High-grade non-Hodgkin's lymphoma: case report 17 October 2013
Neuroblastoma: Complete objective response to biological treatment 28 July 2013
Oesophageal squamocellular carcinoma: a complete and objective response 09 July 2013
Display # 

Page 1 of 2

  • Start
  • Prev
  • 1
  • 2
  • Next
  • End

Search

Follow us...

Latest

  • Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat
  • Radiobiological comparison of flattening filter (FF) and flattening filter-free (FFF) beam in rat laryngeal tissue
  • First Case of Regression of Carcinoid Heart Disease on Serial Transthoracic Echocardiograms following Octreotide Monotherapy in a Patient with Metastatic Pancreatic Neuroendocrine Tumor
  • Somatostatin Receptor Expression in Renal Cell Carcinoma-A New Front in the Diagnostics and Treatment of Renal Cell Carcinoma
  • Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
  • Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility
  • Somatostatin Analogs in Clinical Practice: a Review
  • Radioprotective effect of a combination of melatonin and metformin on mice spermatogenesis: A histological study
  • Melatonin role in the mitochondrial function
  • Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3
  • Melatonin in mitochondrial dysfunction and related disorders
  • Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics
  • The Radioprotective Effect of Combination of Melatonin and Metformin on Rat Duodenum Damage Induced by Ionizing Radiation: A Histological Study
  • Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague-Dawley rat
  • Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion
  • Melatonin synthesis in and uptake by mitochondria: implications for diseased cells with dysfunctional mitochondria
  • Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice
  • Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Bibliography
  • Somatostatin in oncology, the overlooked evidences
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Frequently Asked Questions
  • How effective is chemo therapy?
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
  • The melatonin deception